P W Brandt-Rauf - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P W Brandt-Rauf

Showing results (101-110 of 110) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 110 results.

Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|February 1, 1994

Detection of serum p53 protein in lung cancer patientsJ C Luo, R Zehab, S Anttila, et al.

Experimental Cell Research|December 1, 1992

Evidence that oocyte maturation induced by an oncogenic ras-p21 protein and insulin is mediated by overlapping yet distinct mechanismsD L Chung, A Joran, F Friedman, et al.

International Journal of Cancer|February 1, 1994

Detection of increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humansP W Brandt-Rauf, J C Luo, W P Carney, et al.

Experimental Cell Research|August 30, 2001

Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytesM Ranginwale, S Smith, J Flom, et al.

Cancer Chemotherapy and Pharmacology|August 8, 2001

Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturationC Kovac, L Clie, J Morin, et al.

Annals of Clinical and Laboratory Science|March 18, 2000

Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinaseA Villafania, K Anwar, S Amar, et al.

Breast Cancer Research and Treatment|October 17, 1998

ErbB-2 protein in sera and tumors of breast cancer patientsB Breuer, S Smith, A Thor, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001

Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cellsM Kanovsky, A Raffo, L Drew, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997

Conformation-dependent phosphorylation of p53V Adler, M R Pincus, T Minamoto, et al.

Cancer Chemotherapy and Pharmacology|June 15, 2000

Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathwayL Chie, S Amar, H F Kung, et al.

Pageof 11

Search research articles

Showing results (101-110 of 110) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 110 results.

Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|February 1, 1994

Detection of serum p53 protein in lung cancer patientsJ C Luo, R Zehab, S Anttila, et al.

Experimental Cell Research|December 1, 1992

Evidence that oocyte maturation induced by an oncogenic ras-p21 protein and insulin is mediated by overlapping yet distinct mechanismsD L Chung, A Joran, F Friedman, et al.

International Journal of Cancer|February 1, 1994

Detection of increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humansP W Brandt-Rauf, J C Luo, W P Carney, et al.

Experimental Cell Research|August 30, 2001

Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytesM Ranginwale, S Smith, J Flom, et al.

Cancer Chemotherapy and Pharmacology|August 8, 2001

Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturationC Kovac, L Clie, J Morin, et al.

Annals of Clinical and Laboratory Science|March 18, 2000

Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinaseA Villafania, K Anwar, S Amar, et al.

Breast Cancer Research and Treatment|October 17, 1998

ErbB-2 protein in sera and tumors of breast cancer patientsB Breuer, S Smith, A Thor, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001

Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cellsM Kanovsky, A Raffo, L Drew, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997

Conformation-dependent phosphorylation of p53V Adler, M R Pincus, T Minamoto, et al.

Cancer Chemotherapy and Pharmacology|June 15, 2000

Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathwayL Chie, S Amar, H F Kung, et al.

Pageof 11